AUSA News

February 26, 2020

Cocoon Technology Achieves Development Milestone and Receives First Purchase Order From Thrive

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce Cocoon Technology, LLC (“Cocoon”) is in the final phase of development and completing testing for the platform’s deployment and initial launch with THRIVE Cannabis Marketplace (“THRIVE”) in April 2020.
February 18, 2020

Australis Capital Announces Termination of Merger Agreement with Folium Biosciences

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) previously announced on, December 11, 2019, a proposed merger by and among AUSA, Folium Equity Holding LLC (“Folium”) and Folium Merger Sub, LLC by which Folium would become a wholly owned subsidiary of AUSA, and AUSA would be rebranded as and carry on the business of Folium. AUSA recently discovered new relevant information with regard to Folium and, on that basis, AUSA has decided to not proceed with the merger.
February 11, 2020

Australis Capital to Host Conference Call to Provide Corporate Update

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) today announced that it will host a live conference call to provide a corporate update at 1:00 PM EST on Wednesday, February 26, 2020.
February 4, 2020

Australis Capital Signs Letter of Intent to Acquire Paytron Merchant Services

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce AUSA has entered into a non-binding letter of intent (the “LOI”) to acquire 100% of Paytron, LLC (“Paytron”), a privately held omnichannel payment services provider, which will continue its operations as a wholly-owned subsidiary as well as expand the existing service offering of the Cocoon Technology™ platform.
January 17, 2020

Australis Capital Announces Change in Management

LAS VEGAS, NV, January 17, 2020 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) announced that Mr. Michael Carlotti’s employment with the Company as Chief Financial Officer has been terminated effective January 16, 2020.
January 15, 2020

Tsunami™ and GT Flowers Unite To Take Top Prizes in Concentrates and Vape Cartridges at High Times Cannabis Cup Nevada 2019

LAS VEGAS, NV, January 15, 2020 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce that AUSA’s wholly-owned brands Tsunami™, a science-driven recreational extract brand, and GT Flowers,
January 7, 2020

Australis Capital Strengthens Leadership Team with Chief Accounting Officer Appointment

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce that effective immediately, Alex Han, formerly Vice President of Accounting, has been promoted to Chief Accounting Officer.
December 17, 2019

Australis Capital Signs Agreement with RapidCash ATM

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) announces that it has finalized a vendor agreement with RapidCash ATM Ltd. for the purchase of retail kiosks to be used with AUSA’s Cocoon Technology solution, disclosed in AUSA’s press release dated October 29, 2019. For the kiosks, the Company will issue total consideration of 5 million shares of Body and Mind, Inc. common stock currently held by the Company to RapidCash ATM Ltd.
December 11, 2019

Australis Capital and Folium Biosciences Agree to Merger to Create a Publicly Held Vertically Integrated Producer of Non-Psychoactive Cannabinoids

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (the “Company” or “AUSA”) is pleased to announce it has entered into an agreement and plan of merger by and among AUSA, Folium Equity Holding LLC (“Folium”), and Folium Merger Sub, LLC, a newly formed and wholly-owned Colorado subsidiary of AUSA, (“Merger Sub”) pursuant to which AUSA will acquire (the “Proposed Transaction”) all of the outstanding Folium membership units not already owned by AUSA. The agreement was signed on December 10, 2019. The Proposed Transaction will be completed by way of a merger between Folium and Merger Sub, and Folium will become a wholly owned subsidiary of AUSA. AUSA will be rebranded as Folium Biosciences (the “Resulting Issuer”) prior to the Proposed Transaction and will carry on the current business of Folium.